Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2019 Nov;41(8):606–611. doi: 10.1097/MPH.0000000000001477

Figure 2:

Figure 2:

Estimated Mean Height in centimeters by age of patients (8.0–14.0 years of age) for males and females. Patients categorized as receiving transfusion therapy, hydroxyurea (HU) or no Sickle Cell Disease (SCD) modifying therapy based on the therapy a patient received for the majority of patients. Symbols indicate years at which hypothesis tests for differences in mean were conducted.